132 related articles for article (PubMed ID: 6611180)
1. Association of an interleukin abnormality with the T cell defect in Hodgkin's disease.
Ford RJ; Tsao J; Kouttab NM; Sahasrabuddhe CG; Mehta SR
Blood; 1984 Aug; 64(2):386-92. PubMed ID: 6611180
[TBL] [Abstract][Full Text] [Related]
2. Impaired interleukin regulation of the phytohemagglutinin response in Hodgkin's disease.
Zamkoff KW; Reeves WG; Paolozzi FP; Poiesz BJ; Comis RL; Tomar RH
Clin Immunol Immunopathol; 1985 Apr; 35(1):111-24. PubMed ID: 3922653
[TBL] [Abstract][Full Text] [Related]
3. Impaired T- and B-cell functions in patients with Hodgkin's disease. Reduced mitogenic responsibility and Il-2 production is not caused by defective CD4+-cells.
Bergmann L; Mitrou PS; Demmer-Dieckmann M; Ruhmann FT; Weidmann E
Cancer Immunol Immunother; 1987; 25(1):59-64. PubMed ID: 3496158
[TBL] [Abstract][Full Text] [Related]
4. Impaired proliferative response and low interleukin-2 production in patients with lymphoma.
Musatti CC; Yasaka K; Santos LM
Braz J Med Biol Res; 1987; 20(3-4):351-62. PubMed ID: 3502537
[TBL] [Abstract][Full Text] [Related]
5. In vitro analysis of cell populations involved in Hodgkin's disease lesions and in the characteristic T cell immunodeficiency.
Ford RJ; Rajaraman C; Lu M; Blick M
Hematol Oncol; 1988; 6(3):247-55. PubMed ID: 3261271
[TBL] [Abstract][Full Text] [Related]
6. Defect in lectin-induced interleukin 2 (IL-2) production by peripheral blood lymphocytes of patients with Hodgkin's disease.
Soulillou JP; Douillard JY; Vie H; Harousseau JL; Guenel J; le Mevel-le Pourhiet A; le Mevel B
Eur J Cancer Clin Oncol; 1985 Aug; 21(8):935-9. PubMed ID: 3876220
[TBL] [Abstract][Full Text] [Related]
7. Defective interleukin 2 production in patients after bone marrow transplantation and in vitro restoration of defective T lymphocyte proliferation by highly purified interleukin 2.
Welte K; Ciobanu N; Moore MA; Gulati S; O'Reilly RJ; Mertelsmann R
Blood; 1984 Aug; 64(2):380-5. PubMed ID: 6378275
[TBL] [Abstract][Full Text] [Related]
8. Correlation of blood lymphocyte CTLA-4 (CD152) induction in Hodgkin's disease with proliferative activity, interleukin 2 and interferon-gamma production.
Kosmaczewska A; Frydecka I; Boćko D; Ciszak L; Teodorowska R
Br J Haematol; 2002 Jul; 118(1):202-9. PubMed ID: 12100149
[TBL] [Abstract][Full Text] [Related]
9. Clonal analysis of T lymphocytes in spleens from patients with Hodgkin's disease. Frequent occurrence of unusual T4-positive cells which co-express cytolytic activity and production of interleukin-2.
Romagnani S; Maggi E; Parronchi P; Macchia D; Del Prete GF; Rossi-Ferrini PL; Ricci M; Moretta L
Int J Cancer; 1986 Mar; 37(3):343-9. PubMed ID: 3081452
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3.
Tsoukas CD; Watry D; Escobar SS; Provvedini DM; Dinarello CA; Hustmyer FG; Manolagas SC
J Clin Endocrinol Metab; 1989 Jul; 69(1):127-33. PubMed ID: 2525134
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of immunosuppression associated with severe nonthermal traumatic injuries in man: production of interleukin 1 and 2.
Rodrick ML; Wood JJ; O'Mahony JB; Davis CF; Grbic JT; Demling RH; Moss NM; Saporoschetz I; Jordan A; D'Eon P
J Clin Immunol; 1986 Jul; 6(4):310-8. PubMed ID: 3489002
[TBL] [Abstract][Full Text] [Related]
13. Immunology and cellular biology of Hodgkin's disease.
Slivnick DJ; Nawrocki JF; Fisher RI
Hematol Oncol Clin North Am; 1989 Jun; 3(2):205-20. PubMed ID: 2663823
[TBL] [Abstract][Full Text] [Related]
14. Functional evaluation of T-lymphocytes from peripheral blood and spleens in Hodgkin's disease.
Mukhopadhyaya R; Advani SH; Gangal SG
Br J Cancer; 1987 Dec; 56(6):800-2. PubMed ID: 2829954
[No Abstract] [Full Text] [Related]
15. Cytomegalovirus infection of peripheral blood mononuclear cells: effects on interleukin-1 and -2 production and responsiveness.
Kapasi K; Rice GP
J Virol; 1988 Oct; 62(10):3603-7. PubMed ID: 2843662
[TBL] [Abstract][Full Text] [Related]
16. Role of suppressor cells in depression of T lymphocyte proliferative response in untreated and treated Hodgkin's disease.
Han T
Cancer; 1980 Apr; 45(8):2102-8. PubMed ID: 6445226
[TBL] [Abstract][Full Text] [Related]
17. Studies of cell subpopulations mediating mitogen hyporesponsiveness in patients with Hodgkin's disease.
Sibbitt WL; Bankhurst AD; Williams RC
J Clin Invest; 1978 Jan; 61(1):55-63. PubMed ID: 304068
[TBL] [Abstract][Full Text] [Related]
18. Nature of the T lymphocytes in lymphocyte predominance Hodgkin's disease.
Dargent JL; Schandene L; Kornreich A; Lespagnard L; Cochaux P; Jagodzinski R; Capel P; Velu T; Neve P
Leuk Lymphoma; 1997 Feb; 24(5-6):545-51. PubMed ID: 9086445
[TBL] [Abstract][Full Text] [Related]
19. T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28.
Renner C; Ohnesorge S; Held G; Bauer S; Jung W; Pfitzenmeier JP; Pfreundschuh M
Blood; 1996 Jul; 88(1):236-41. PubMed ID: 8704179
[TBL] [Abstract][Full Text] [Related]
20. Immunodeficiencies in Hodgkin's disease. Part I: T cell-mediated immunity.
Gupta S
Clin Bull; 1981; 11(2):58-65. PubMed ID: 6459892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
